According to Cellectis's latest financial reports and stock price the company's current number of shares outstanding is 55,583,768. At the end of 2023 the company had 55,583,768 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 55.58 M | 22.3% |
2022 | 45.44 M | 6.33% |
2021 | 42.74 M | 0.36% |
2020 | 42.58 M | 0.32% |
2019 | 42.45 M | 0.05% |
2018 | 42.43 M | 18.03% |
2017 | 35.94 M | 1.74% |
2016 | 35.33 M | 0.59% |
2015 | 35.12 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Regeneron Pharmaceuticals REGN | 106,300,000 | 91.24% | ๐บ๐ธ USA |
uniQure QURE | 47,770,101 | -14.06% | ๐ณ๐ฑ Netherlands |
Novavax NVAX | 103,429,000 | 86.08% | ๐บ๐ธ USA |
Flexion Therapeutics
FLXN | 38,562,800 | -30.62% | ๐บ๐ธ USA |